Sesamol Reduces the Atherogenicity of Electronegative L5 LDL in Vivoand in Vitro

Highly electronegative low-density lipoprotein (LDL) L5 induces endothelial cell (EC) apoptosis, which leads to the development of atherosclerosis. We examined the effects of sesamol (1), a natural organic component of sesame oil, on plasma L5 levels and atherosclerosis development in a rodent model and on the L5-induced apoptosis of ECs. Syrian hamsters, which have an LDL profile similar to that of humans, were fed a normal chow diet (control), a high-fat diet (HFD), or a HFD supplemented with the administration of 50 or 100 mg/kg of 1via oral gavage (HFD+1) for 16 weeks (n = 8 per group). Hamsters in the HFD+1groups had reduced plasma L5 levels when compared with the HFD group. Oil Red O staining showed that atherosclerotic lesion size was markedly reduced in the aortic arch of hamsters in the HFD+1groups when compared with that in the HFD group. In human aortic ECs, 0.3–3 μM 1blocked L5-induced apoptosis in a dose-dependent manner. Further mechanistic studies showed that 1inhibited the L5-induced lectin-like oxidized LDL receptor-1 (LOX-1)−dependent phosphorylation of p38 MAPK and activation of caspase-3 and increased phosphorylation of eNOS and Akt. Our findings suggest that sesamol (1) protects against atherosclerosis by reducing L5-induced atherogenicity.